Remove Clinical Trials Remove Drug Development Remove Trials
article thumbnail

How Clinical Trial Trends are Redefining Drug Development

Quanticate

With the implementation of technology rapidly increasing, stricter regulatory standards, and growing demand for innovative treatments, the trends within the industry continue to evolve, impacting the future of clinical trials both positively and negatively.

article thumbnail

ML could facilitate increased adoption of adaptive clinical trials

Drug Discovery World

A new machine learning (ML) software platform has been launched to facilitate wider adoption of advanced and adaptive clinical trials. Novel Response Adaptive Randomization (RAR) capabilities that support multi-interims in a trial while maintaining interactivity and accuracy at the highest standards.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI and machine learning: A new era for clinical trials

Drug Discovery World

Fiona Maini , Senior Director Global Compliance & Strategy, at Medidata looks at the rise of artificial intelligence (AI) and machine learning (ML) within life sciences and the applications for the technology in clinical trials.

article thumbnail

Clinical trial to repurpose HIV drugs to treat brain tumours

Drug Discovery World

Drugs developed to treat HIV and AIDS are being trialled for the first time in patients with multiple brain tumours. The rare inherited genetic condition causes tumours such as schwannoma (which include acoustic neuroma), ependymoma and meningioma which develop on the membrane surrounding the brain.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

article thumbnail

Decoding diseases: The AI renaissance in clinical trials

Drug Discovery World

Deepika Khedekar , Associate Centralized Clinical Lead at IQVIA, explains how artificial intelligence could make clinical trials more accurate, accessible and standardised. Tapping into the capabilities of AI One reason AI may accelerate clinical trials is its ability to rapidly process and analyse vast amounts of data.

article thumbnail

A step closer to ‘clinical trial in a dish’ for Alzheimer’s  

Drug Discovery World

Grown in vitro, these cells can provide patient specific human brain models from a large cohort of AD patients – to create a ‘clinical trial in a dish’. The recent US Federal Food and Drug Administration Agency (FDA) Modernization Act 2.0